DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Awada A, Cardoso F, Fontaine C, Dirix L, De Greve J, Sotiriou C, Steinseifer J, Wouters C, Tanaka C, Zoellner U, Tang P, Piccart M.
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics.
Eur J Cancer 2008; 44: 84-91
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.